[Impact of nuclear medicine imaging techniques for lymph node surgery]

Area of Science:

• Nuclear medicine
• Molecular imaging
• Uro-oncology

Background:

• Nuclear medicine imaging enables noninvasive in vivo visualization of molecular processes.
• Lymph node management is critical in uro-oncology for staging and treatment.
• Sentinel lymph node biopsy is a key diagnostic procedure.

Purpose of the Study:

• To review molecular nuclear imaging techniques in uro-oncology.
• To highlight the clinical potential of positron emission tomography (PET) and sentinel lymph node identification.
• To discuss future trends in molecular imaging for uro-oncology.

Main Methods:

• Review of nuclear medicine imaging techniques.
• Focus on positron emission tomography (PET) for staging, restaging, and follow-up.
• Description of preoperative sentinel lymph node identification and biopsy.

Main Results:

• PET is valuable for staging, restaging, and follow-up in uro-oncology.
• Preoperative sentinel lymph node identification facilitates targeted biopsy.
• These techniques offer significant clinical potential for patient management.

Conclusions:

• Nuclear medicine imaging, particularly PET, is crucial for uro-oncology.
• Sentinel lymph node biopsy guided by molecular imaging improves surgical precision.
• Future advancements in molecular imaging will further benefit uro-oncology patient care.